Cargando…
Clofarabine in Pediatric Acute Relapsed or Refractory Leukemia: Where Do We Stand on the Bridge to Hematopoietic Stem Cell Transplantation?
BACKGROUND: Despite pronounced improvement in overall survival (OS) in pediatric leukemia, a proportion of patients continue to suffer from lack of response or relapse, and the management of such patients is exceedingly difficult. Immunotherapy and engineered chimeric antigen receptor (CAR) T-cell t...
Autores principales: | Ramiz, Sarah, Elhaj, Osama, Siddiqui, Khawar, Khan, Saadiya, AlSaedi, Hawazen, AlAnazi, Awatif, Al-Ahmari, Ali, Al-Jefri, Abdullah, Sahvan, Oudai, Ayas, Mouhab, Ghemlas, Ibrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990710/ https://www.ncbi.nlm.nih.gov/pubmed/36895294 http://dx.doi.org/10.14740/jh1065 |
Ejemplares similares
-
Can the bone marrow harvest volume be reduced safely in hematopoietic stem cell transplantation with pediatric sibling donors?
por: AlAnazi, Awatif, et al.
Publicado: (2023) -
Outcomes of blood and marrow transplantation in children less than 2-years of age: 23 years of experience at a single center
por: Khan, Saadiya, et al.
Publicado: (2022) -
Hematopoietic Stem Cell Transplantation Stabilizes Cerebral Vasculopathy in High-Risk Pediatric Sickle Cell Disease Patients: Evidence From a Referral Transplant Center
por: Al-Jefri, Abdullah, et al.
Publicado: (2022) -
Pediatric high risk neuroblastoma with autologous stem cell transplant – 20 years of experience
por: Khan, Saadiya, et al.
Publicado: (2021) -
Outcome of pediatric chronic myeloid leukemia with management focusing on the monitoring of BCR-ABL fusion gene transcript levels
por: Al-Ghemlas, Ibrahim, et al.
Publicado: (2022)